<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Putting evidence into practice: interventions for depression.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Fulcher CD, Badger T, Gunter AK, Marrs JA, Reese JM. Putting evidence into practice: interventions for depression. Clin J Oncol Nurs. 2008 Feb;12(1):131-40. [46 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18258583&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Oncology Nursing Society (ONS) reaffirmed the currency of this guideline in 2011.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Behavior therapy  (94.33); Hypnotherapy  (94.32); Major depressive affective disorder, recurrent episode, unspecified  (296.30); Major depressive affective disorder, single episode, unspecified  (296.20); Neoplasm of unspecified nature, site unspecified  (239.9)"/><FieldValue Value="MSH: Acupuncture Therapy ; Antidepressive Agents ; Aromatherapy ; Behavior Therapy ; Cognitive Therapy ; Complementary Therapies ; Counseling ; Depression ; Depressive Disorder ; Depressive Disorder, Major ; Dietary Supplements ; Exercise ; Herbal Medicine ; Hypnosis ; Massage ; Meditation ; Methylphenidate ; Neoplasms ; Patient Education as Topic ; Phytotherapy ; Psychotherapy ; Relaxation Therapy ; Social Support ; Yoga "/><FieldValue Value="MTH: Acupuncture procedure ; Antidepressive Agents ; Aromatherapy ; cancer-related problem/condition ; Cognitive Therapy ; Complementary therapies ; Counseling ; Depressive Disorder ; Dietary Supplements ; Discipline of Herbal Medicine ; Exercise ; Hypnotherapy ; MAJOR DEPRESSIVE DISORDER ; Massage ; meditation ; Mental Depression ; Methylphenidate ; Neoplasm of unspecified nature, site unspecified ; Neoplasms ; Nutrition management ; Patient education (procedure) ; Phytotherapy ; Psychosocial assessment (procedure) ; Psychotherapy ; Social support ; Yoga "/><FieldValue Value="PDQ: acupuncture ; aromatherapy ; cancer-related problem/condition ; herbal medicine / botanical therapy ; hypnosis ; yoga "/><FieldValue Value="SNOMEDCT_US: Acupuncture  (44868003); Antidepressant  (36236003); Antidepressant  (372720008); Aromatherapy  (394615007); Behavioral therapy  (166001); Cognitive therapy  (183383008); Cognitive therapy  (228553007); Cognitive therapy  (228557008); Cognitive therapy  (304891004); Complementary therapy  (225423004); Counseling  (129441002); Counseling  (409063005); Depressive disorder  (21061000119107); Depressive disorder  (35489007); Exercise  (183301007); Exercise  (256235009); Exercise  (61686008); Herbal therapy  (414392008); Hypnotherapy  (183408002); Hypnotherapy  (19997007); Major depressive disorder  (370143000); Methylphenidate  (18548003); Methylphenidate  (373337007); Neoplasm  (108369006); Nutrition management  (386372009); Nutritional supplement  (108961000); Nutritional supplement  (226279009); Nutritional supplement  (373453009); Patient education  (311401005); Psychosocial analysis assessment  (371585000); Psychosocial analysis assessment  (408920002); Psychotherapy  (75516001); Recurrent major depressive episodes  (268621008); Recurrent major depressive episodes  (66344007); Relaxation training therapy  (64299003); Single major depressive episode  (268620009); Single major depressive episode  (36923009)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Cancer-related depression&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Depression is defined for this review as the entire range of feelings and emotions expressed by individuals with cancer as they manage personal and illness-related problems; it includes normal sadness in response to loss as well as chronic, depressed emotional affect and clinical depression that meets specific criteria for a psychiatric disorder.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Evaluation" /><FieldValue Value="Screening" /><FieldValue Value="Treatment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Nursing" /><FieldValue Value="Oncology" /><FieldValue Value="Psychiatry" /><FieldValue Value="Psychology" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Nurses" /><FieldValue Value="Psychologists/Non-physician Behavioral Health Clinicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To provide recommendations for the treatment of cancer-related depression.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Patients with cancer-related depression&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Psychoeducational and psychosocial interventions including cognitive-behavioral therapy, patient education and information, counseling and psychotherapy, behavioral therapy, and supportive interventions &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pharmacologic interventions&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Antidepressant medications &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Methylphenidate &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Complementary interventions&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Massage therapy &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Relaxation therapy &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Hypnotherapy &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Exercise &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Other interventions including nutritional and herbal supplements, yoga, acupuncture, aromatherapy, and meditation &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Signs and symptoms of depression &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Severity of depression &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Quality of life &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;2008 Original Guideline&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The workgroup searched MEDLINE&amp;reg;, CINAHL&amp;reg;, PubMed&amp;reg;, and PsycINFO using the search terms &lt;em&gt;interventions, psychosocial interventions, psychoeducational interventions, supportive counseling&lt;/em&gt;, and &lt;em&gt;cancer&lt;/em&gt; and &lt;em&gt;depressive symptoms&lt;/em&gt; or &lt;em&gt;depression&lt;/em&gt; or &lt;em&gt;major depressive disorder&lt;/em&gt;. Years searched were 2001&amp;ndash;2006, and the search ended September 30, 2006. In some cases, earlier articles were reviewed in an attempt to comprehensively cover appropriate literature.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Articles were eliminated if they did not involve an intervention targeted for depressive symptoms or major depressive disorder, or if they were exclusively about caregivers or pediatric patients. A health services librarian was consulted to assist in the search.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;2011 Reaffirmation&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;PubMed, CINAHL and Cochrane Collaboration were searched from March 2008 through June 2011 using the search terms: (depress*[ti] OR depression[majr]) AND (Therapy/Broad[filter] OR systematic[sb]). Limits: Cancer.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Inclusion Criteria&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Full research report, systematic review, guideline or meta-analysis &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Study must report results of measurement of depression or depressive symptoms &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The study examines an intervention aimed at affecting the symptom &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Study sample must include patients with cancer&lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusion Criteria&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Grey literature&lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;Monthly auto alerts from all databases are received. Abstracts are reviewed against inclusion and exclusion criteria, and those meeting criteria are selected to be obtained. Further full article review is done by team members assigned, and any that does not meet criteria upon full review is eliminated.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Expert Consensus (Committee)" /><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Panels of advanced practice nurses, staff nurses, and doctorally-prepared nurse researchers reviewed the literature base in the identified outcome areas. Professional health services librarians assisted in the conduct of the literature searches. Based on their analysis, the panels then formulated a judgment about the body of evidence related to the intervention under consideration. Three major components were considered by the panels in classifying the collective evidence into one of six Weight of Evidence categories (see the &quot;Rating Scheme for the Strength of the Recommendations&quot; field):&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Quality of the data, with more weight assigned to levels of evidence higher in the PRISM categorization (such as randomized trials and meta-analyses) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Magnitude of the outcome (e.g., effect size or minimal clinically important difference) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Concurrence among the evidence (based on the premise that an investigator has less confidence in findings in which the lines of evidence contradict one another) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review with Evidence Tables" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus (Consensus Development Conference)" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;2008 Original Document&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Not stated&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2012 Reaffirmation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The committee met on July 11, 2013. The team consisting of nurse scientists, advanced practice nurses and staff nurses write summaries of all references retrieved for the topic and appraise the evidence based on study design, settings and sample characteristics. All evidence findings for each intervention is synthesized. The synthesized information is provided to all team members for review, and after review, the team members meet via a web meeting and conference call to apply the &lt;a href=&quot;http://www.ons.org/Research/media/ons/docs/research/outcomes/weight-of-evidence-table.pdf&quot; title=&quot;ONS Web site&quot;&gt;PEP Weight of Evidence Classification criteria&lt;/a&gt;. In this meeting the group decides upon the classification of the evidence for each intervention found in the search, reviews the set of references to determine if any key references are not included, and ensures consistency of intervention definitions and associated evidence summaries. Further team communication and decision making is done via email and follow up phone conferences as needed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Recommended for Practice&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which effectiveness has been demonstrated by strong evidence from rigorously designed studies, meta-analyses, or systematic reviews, and for which expectation of harms is small compared with the benefits&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from at least two well-conducted randomized controlled trials that were performed at more than one institutional site and that included a sample size of at least 100 participants &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a meta-analysis or systematic review of research studies that incorporated quality ratings in the analysis and included a total of 100 patients or more in its estimate of effect size and confidence intervals &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Recommendations from a panel of experts, that derive from an explicit literature search strategy, and include thorough analysis, quality rating, and synthesis of the evidence &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Likely To Be Effective&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which the evidence is less well established than for those listed under &quot;Recommended for Practice&quot;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from a single well conducted randomized controlled trial that included fewer than 100 patients or was conducted at one or more institutions &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a meta-analysis or systematic review that incorporated quality ratings in the analysis and included fewer than 100 patients, or had no estimates of effect size and confidence intervals &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a synthetic review of randomized trials that incorporated quality ratings in the analysis &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Guidelines developed largely by consensus/expert opinion rather than primarily based on the evidence and published by a panel of experts, that are not supported by synthesis and quality rating of the evidence &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Benefits Balanced With Harm&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which clinicians and patients should weigh the beneficial and harmful effects according to individual circumstances and priorities&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from one or more randomized trials, meta-analyses, or systematic reviews, but where the intervention may be associated, in certain patient populations, with adverse effects that produce or potentially produce mortality, significant morbidity, functional disability, hospitalization, or excess length of stay &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Effectiveness Not Established&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which there are currently insufficient data or data of inadequate quality&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from a well conducted case control study &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from a poorly controlled or uncontrolled study&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Evidence from randomized clinical trials with one or more major or three or more minor methodological flaws that could invalidate the results &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Evidence from non-experimental studies with high potential for bias (such as case series with comparison to historical controls)-Evidence from case series or case reports &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Conflicting evidence, but where the preponderance of the evidence is in support of the recommendation or meta-analysis showing a trend that did not reach statistical significance &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Effectiveness Unlikely&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which lack of effectiveness is less well established than for those listed under &quot;Not Recommended for Practice&quot;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a single well conducted randomized trial with at least 100 participants or conducted at more than one site and which showed no benefit for the intervention &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a well conducted case control study, a poorly controlled or uncontrolled study, a randomized trial with major methodologic flaws, or an observational study (e.g., case series with historical controls) that showed no benefit and a prominent and unacceptable pattern of adverse events and serious toxicities &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Not Recommended for Practice&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which ineffectiveness or harmfulness has been demonstrated by clear evidence, or the cost or burden necessary for the intervention exceeds anticipated benefit&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Evidence from two or more well conducted randomized trials with at least 100 participants or conducted at more than one site and which showed no benefit for the intervention and excessive costs or burden expected &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a single well conducted trial that showed a prominent and unacceptable pattern of adverse events and serious toxicities &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a meta-analysis or systematic review of research studies that incorporated quality ratings in the analysis, included a total of 100 patients or more in its estimate of effect size and confidence intervals with demonstrated lack of benefit or prominent and unacceptable toxicities &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Intervention discouraged from use by a panel of experts in the related subject, after conducting a systematic examination, quality rating and synthesis of the available evidence &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This guideline was accepted for publication on October 26, 2007.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;em&gt;Note from the National Guideline Clearinghouse&lt;/em&gt;&lt;/strong&gt;: Recommendations have been taken from the Oncology Nursing Society Putting Evidence Into Practice (ONS PEP) quick view resource (see the &quot;Availability of Companion Documents&quot; field). Refer to the original guideline document for full dosages, references, and other essential information about the evidence.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommended for Practice&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Psychoeducational/psychosocial interventions &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Antidepressant medications &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Likely To Be Effective&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Methylphenidate (Ritalin&amp;reg;, Novartis) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Relaxation therapy &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Effectiveness Not Established&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Exercise &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hypnotherapy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Massage therapy &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Special Considerations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Complementary methods such as St. John's wort or other nutritional and herbal supplements, yoga, acupuncture, aromatherapy, and meditation have not been studied specifically in the setting of patients with cancer and depression. Some of these interventions may benefit quality of life or even mood; however, they should not be generalized to depression. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommended for Practice&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which effectiveness has been demonstrated by strong evidence from rigorously designed studies, meta-analyses, or systematic reviews, and for which expectation of harms is small compared with the benefits&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from at least two well-conducted randomized controlled trials that were performed at more than one institutional site and that included a sample size of at least 100 participants &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a meta-analysis or systematic review of research studies that incorporated quality ratings in the analysis and included a total of 100 patients or more in its estimate of effect size and confidence intervals &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Recommendations from a panel of experts, that derive from an explicit literature search strategy, and include thorough analysis, quality rating, and synthesis of the evidence &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Likely To Be Effective&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which the evidence is less well established than for those listed under &quot;Recommended for Practice&quot;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from a single well conducted randomized controlled trial that included fewer than 100 patients or was conducted at one or more institutions &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a meta-analysis or systematic review that incorporated quality ratings in the analysis and included fewer than 100 patients, or had no estimates of effect size and confidence intervals &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a synthetic review of randomized trials that incorporated quality ratings in the analysis &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Guidelines developed largely by consensus/expert opinion rather than primarily based on the evidence and published by a panel of experts, that are not supported by synthesis and quality rating of the evidence &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Benefits Balanced With Harm&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which clinicians and patients should weigh the beneficial and harmful effects according to individual circumstances and priorities&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from one or more randomized trials, meta-analyses, or systematic reviews, but where the intervention may be associated, in certain patient populations, with adverse effects that produce or potentially produce mortality, significant morbidity, functional disability, hospitalization, or excess length of stay &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Effectiveness Not Established&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which there are currently insufficient data or data of inadequate quality&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from a well conducted case control study &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Supportive evidence from a poorly controlled or uncontrolled study&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Evidence from randomized clinical trials with one or more major or three or more minor methodological flaws that could invalidate the results &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Evidence from non-experimental studies with high potential for bias (such as case series with comparison to historical controls)-Evidence from case series or case reports &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Conflicting evidence, but where the preponderance of the evidence is in support of the recommendation or meta-analysis showing a trend that did not reach statistical significance &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Effectiveness Unlikely&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which lack of effectiveness is less well established than for those listed under &quot;Not Recommended for Practice&quot;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a single well conducted randomized trial with at least 100 participants or conducted at more than one site and which showed no benefit for the intervention &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a well conducted case control study, a poorly controlled or uncontrolled study, a randomized trial with major methodologic flaws, or an observational study (e.g., case series with historical controls) that showed no benefit and a prominent and unacceptable pattern of adverse events and serious toxicities &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Not Recommended for Practice&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions for which ineffectiveness or harmfulness has been demonstrated by clear evidence, or the cost or burden necessary for the intervention exceeds anticipated benefit&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Evidence from two or more well conducted randomized trials with at least 100 participants or conducted at more than one site and which showed no benefit for the intervention and excessive costs or burden expected &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a single well conducted trial that showed a prominent and unacceptable pattern of adverse events and serious toxicities &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence from a meta-analysis or systematic review of research studies that incorporated quality ratings in the analysis, included a total of 100 patients or more in its estimate of effect size and confidence intervals with demonstrated lack of benefit or prominent and unacceptable toxicities &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Intervention discouraged from use by a panel of experts in the related subject, after conducting a systematic examination, quality rating and synthesis of the available evidence &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of evidence is specifically stated for each recommendation (see &quot;Major Recommendations&quot; field).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Appropriate treatment for adult patients with cancer and depression &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Intervening to diminish depressive symptoms in people with cancer is important because depression has been associated with poorer quality of life, recovery, and possibly survival. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;St. John's wort, an herb known to treat mild to moderate depression, should be avoided during chemotherapy or radiation or when surgery is planned because it can adversely impact the efficacy of some chemotherapeutic agents and prescription medications.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;See the &quot;Appendix. Putting Evidence Into Practice&amp;reg; Card on Depression in Patients with Cancer&quot; in the original guideline document for more information.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This content published by the Oncology Nursing Society (ONS), reflects a scientific literature review. There is no representation nor guarantee that the practices described herein will, if followed, ensure safe and effective patient care. The descriptions reflect the state of general knowledge and practice in the field as described in the literature as of the date of the scientific literature review. The descriptions may not be appropriate for use in all circumstances. Those who use this content should make their own determinations regarding safe and appropriate patient care practices, taking into account the personnel, equipment, and practices available at their healthcare facility. ONS does not endorse the practices described herein. The editors and publisher cannot be held responsible for any liability incurred as a consequence of the use or application of any of this content.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An implementation strategy was not provided.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Patient Resources" /><FieldValue Value="Quick Reference Guides/Physician Guides" /><FieldValue Value="Resources" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Fulcher CD, Badger T, Gunter AK, Marrs JA, Reese JM. Putting evidence into practice: interventions for depression. Clin J Oncol Nurs. 2008 Feb;12(1):131-40. [46 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18258583&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2008 Feb 1 (reaffirmed 2011)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Oncology Nursing Society - Professional Association" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Oncology Nursing Society&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Oncology Nursing Society Putting Evidence Into Practice&amp;reg; (ONS PEP) project team&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Authors&lt;/em&gt;: Caryl D. Fulcher, MSN, APRN, BC; Terry Badger, PhD, APRN, BC, FAAN; Ashley K. Gunter, BSN, RN, OCN&amp;reg;; Joyce A. Marrs, MS, APRN, BC, AOCNP&amp;reg;; Jill M. Reese, BSN, RN, OCN&amp;reg;&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;No financial relationships to disclose.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Oncology Nursing Society (ONS) reaffirmed the currency of this guideline in 2011.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://ons.metapress.com/content/l58q05783728n170/fulltext.pdf&quot; title=&quot;ONS Web site&quot;&gt;Oncology Nursing Society (ONS) Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available for purchase from the Oncology Nursing Society, 125 Enterprise Drive, Pittsburgh, PA 15275-1214; telephone, 412-859-6100; fax, 412-921-6565. The ONS Publications Catalog is available online at the &lt;a href=&quot;http://www.ons.org/&quot; title=&quot;ONS Web site&quot;&gt;Oncology Nursing Society (ONS) Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Oncology Nursing Society's Putting Evidence Into Practice (ONS PEP) depression evidence table. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.ons.org/Research/PEP/media/ons/docs/research/outcomes/depression/table-of-evidence.pdf&quot; title=&quot;ONS Web site&quot;&gt;Oncology Nursing Society (ONS) Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;ONS PEP depression clinical practice guidelines table. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.ons.org/Research/PEP/media/ons/docs/research/outcomes/depression/guidelines.pdf&quot; title=&quot;ONS Web site&quot;&gt;ONS Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;ONS PEP depression systematic review/meta-analysis table. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.ons.org/Research/PEP/media/ons/docs/research/outcomes/depression/review-table.pdf&quot; title=&quot;ONS Web site&quot;&gt;ONS Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;ONS PEP quick view for depression. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.ons.org/Research/PEP/media/ons/docs/research/outcomes/depression/quickview.pdf&quot; title=&quot;ONS Web site&quot;&gt;ONS Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nursing-sensitive patient outcomes: the development of the putting evidence into practice resources for nursing practice. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://ons.metapress.com/content/037248216wm2k054/fulltext.pdf&quot; title=&quot;ONS Web site&quot;&gt;ONS Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Chemotherapy and biotherapy guidelines and recommendations for practice. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.ons.org/Publications/Books/Excerpts/INPU0590toc/&quot; title=&quot;ONS Web site&quot;&gt;ONS Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Measuring oncology nursing-sensitive patient outcomes: measurement summary. Depression. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.ons.org/Research/PEP/media/ons/docs/research/measurement/depression.pdf&quot; title=&quot;ONS Web site&quot;&gt;ONS Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;ONS PEP weight of evidence classification schema. Decision rules for summative evaluation of a body of evidence. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.ons.org/Research/media/ons/docs/research/outcomes/weight-of-evidence-table.pdf&quot; title=&quot;ONS Web site&quot;&gt;ONS Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Patient-focused instruction sheets are available from &lt;a href=&quot;http://www.thecancerjourney.org&quot; title=&quot;The Cancer Journey Web site&quot;&gt;www.thecancerjourney.org&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on December 2, 2010. The information was verified by the guideline developer on February 3, 2011. The currency of the guideline was reaffirmed by the developer in 2011 and this summary was updated by ECRI Institute on November 8, 2013. This summary was updated by ECRI Institute on April 7, 2014 following the U.S. Food and Drug Administration advisory on Methylphenidate ADHD Medications.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This summary is based on the original guideline, which is copyrighted by the Oncology Nursing Society (ONS).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
